Checkpoint Therapeutics, Inc.

Pharmaceutical Preparations·WALTHAM, MA

CEO

Oliviero James F Iii

CFO

Gray William Garrett

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q1 2025	3/31/25	5/13/25	→
10-K	FY 2024	12/31/24	3/28/25	→
10-Q	Q3 2024	9/30/24	11/12/24	→
10-Q	Q2 2024	6/30/24	8/12/24	→
10-Q	Q1 2024	3/31/24	5/10/24	→
10-K	FY 2023	12/31/23	3/22/24	→
↓

Earnings Releases (8-K)

30 shown

Filed	Period
5/13/25	Q2 FY2025	→
3/28/25	Q1 FY2025	→
11/12/24	Q4 FY2024	→
8/12/24	Q3 FY2024	→
5/10/24	Q2 FY2024	→
3/22/24	Q1 FY2024	→
↓

News (8-K)

50 shown

Filed	Type	Description
5/30/25	Delisting	Termination of a Material Definitive Agreement	→
5/29/25	Vote	Submission of Matters to a Vote of Security Holders	→
5/22/25	Other	Other Events	→
4/15/25	Agreement	FROM 8-K	→
3/10/25	Agreement	Entry into a Material Definitive Agreement	→
1/10/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

36 shown

Filed	Form	Description
5/30/25	S-8 POS	S-8 POS	→
5/30/25	S-8 POS	S-8 POS	→
5/30/25	S-8 POS	S-8 POS	→
5/30/25	S-8 POS	S-8 POS	→
5/30/25	S-8 POS	S-8 POS	→
5/30/25	S-8 POS	S-8 POS	→
↓

Filing History(420 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13G/A

Aug 14, 2025

0000935836-25-000512

—

22.1 KB

15-12G

Jun 9, 2025

0001104659-25-05762115-12G

—

10.6 KB

EFFECT

Jun 4, 2025

9999999995-25-001826

—

1.7 KB

EFFECT

Jun 4, 2025

9999999995-25-001823

—

1.7 KB

EFFECT

Jun 4, 2025

9999999995-25-001822

—

1.7 KB

EFFECT

Jun 4, 2025

9999999995-25-001821

—

1.7 KB

EFFECT

Jun 4, 2025

9999999995-25-001820

—

1.7 KB

EFFECT

Jun 4, 2025

9999999995-25-001819

—

1.7 KB

SCHEDULE 13D/A

Jun 3, 2025

0001104659-25-056072

—

10.5 KB

Jun 3, 2025

0001415889-25-015470

May 29, 2025

10.5 KB

25-NSE

May 30, 2025

0001354457-25-000474

—

2.9 KB

May 30, 2025

0001104659-25-054698OWNERSHIP DOCUMENT

May 28, 2025

8.8 KB

May 30, 2025

0001104659-25-054695OWNERSHIP DOCUMENT

May 28, 2025

6.9 KB

May 30, 2025

0001104659-25-054692OWNERSHIP DOCUMENT

May 28, 2025

8.5 KB

May 30, 2025

0001104659-25-054690OWNERSHIP DOCUMENT

May 30, 2025

5.3 KB

May 30, 2025

0001104659-25-054688OWNERSHIP DOCUMENT

May 28, 2025

6.9 KB

May 30, 2025

0001104659-25-054687OWNERSHIP DOCUMENT

May 30, 2025

5.3 KB

May 30, 2025

0001104659-25-054686OWNERSHIP DOCUMENT

May 28, 2025

6.9 KB

May 30, 2025

0001104659-25-054684OWNERSHIP DOCUMENT

May 28, 2025

7.0 KB

S-8 POS

May 30, 2025

0001104659-25-054647S-8 POS

—

23.9 KB

S-8 POS

May 30, 2025

0001104659-25-054646S-8 POS

—

23.9 KB

S-8 POS

May 30, 2025

0001104659-25-054645S-8 POS

—

23.9 KB

S-8 POS

May 30, 2025

0001104659-25-054642S-8 POS

—

23.9 KB

S-8 POS

May 30, 2025

0001104659-25-054640S-8 POS

—

23.9 KB

S-8 POS

May 30, 2025

0001104659-25-054639S-8 POS

—

23.9 KB

25 filings shown

Filed	Form	Description
4/23/25	DEFM14A	DEFM14A	→
4/15/25	DEFA14A	DEFA14A	→
4/14/25	PREM14A	PREM14A	→
3/10/25	DEFA14A	DEFA14A	→
3/10/25	DEFA14A	DEFA14A	→
4/2/24	DEFA14A	DEFA14A	→
↓

Checkpoint Therapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(420 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
6/3/25	4	4	→
5/30/25	4	OWNERSHIP DOCUMENT	→
5/30/25	4	OWNERSHIP DOCUMENT	→
5/30/25	4	OWNERSHIP DOCUMENT	→
5/30/25	4	OWNERSHIP DOCUMENT	→
5/30/25	4	OWNERSHIP DOCUMENT	→
↓

Filed	Form	Description
8/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
6/9/25	15-12G	15-12G	→
6/4/25	EFFECT	EFFECT	→
6/4/25	EFFECT	EFFECT	→
6/4/25	EFFECT	EFFECT	→
6/4/25	EFFECT	EFFECT	→
↓